A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits
- Author
- KUSCHNER, Robert A1 ; RUSSELL, Kevin L2 ; QI LIU5 ; LYONS, Arthur G1 ; MALIK, Mohammad4 ; MOON, James E1 ; STUBBS, Jeremiah1 ; SUN, Wellington1 ; TANG, Doug1 ; TOWLE, Andrew C6 ; WALSH, Douglas S1 ; WILKERSON, Deborah3 ; ABUJA, Mary2 ; BAUER, Kristen M1 ; FAIX, Dennis J2 ; HAIT, Howard3 ; HENRICK, Jennifer3 ; JACOBS, Michael4 ; LISS, Alan3 ; LYNCH, Julia A1
[1] Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD, United States
[2] Naval Health Research Center, 140 Sylvester Avenue, San Diego, CA, United States
[3] Barr Laboratories Inc., 2 Quaker Road, Pomona, NY, United States
[4] Captain James A Lovell Federal Health Care Center, 3001 Green Bay Road, North Chicago, IL, United States
[5] Barr Laboratories, 8 Delaney Drive, Newtown, PA, United States
[6] VaccGen International LLC, 8 Cambridge Court, Larchmont, NY, United States
Adenovirus Vaccine Efficacy Trial Consortium - Source
Vaccine. 2013, Vol 31, Num 28, pp 2963-2971, 9 p ; ref : 25 ref
- Publisher
- Elsevier, Kidlington
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- ADV-4 ADV-7 Acute respiratory infection Adenovirus Type 4 and Type 7 vaccine, live Adenovirus Type 4 Adenovirus Type 7 Live vaccines Oral vaccine oral
- Keyword (fr)
- Adénovirus 4 Adénovirus 7 Aigu Efficacité Pathologie de l'appareil respiratoire Vaccin Adenoviridae Adénovirus humain Mastadenovirus Virus
- Keyword (en)
- Adenovirus 4 Adenovirus 7 Acute Efficiency Respiratory disease Vaccine Adenoviridae Human adenovirus Mastadenovirus Virus
- Keyword (es)
- Adenovirus 4 Adenovirus 7 Agudo Eficacia Aparato respiratorio patología Vacuna Adenoviridae Human adenovirus Mastadenovirus Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05C Virology / 002A05C10 Miscellaneous
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05F Applied microbiology / 002A05F04 Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
- Discipline
- Microbiology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27512621
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.vaccine.2013.04.035 
https://dx.doi.org/10.1016/j.vaccine.2013.04.035
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2013.04.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:2:\"28\";s:8:\"\u0000*\u0000spage\";s:4:\"2963\";s:8:\"\u0000*\u0000epage\";s:4:\"2971\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KUSCHNER\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Robert A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:16:\"RUSSELL, Kevin L\";i:1;s:6:\"QI LIU\";i:2;s:15:\"LYONS, Arthur G\";i:3;s:15:\"MALIK, Mohammad\";i:4;s:13:\"MOON, James E\";i:5;s:16:\"STUBBS, Jeremiah\";i:6;s:15:\"SUN, Wellington\";i:7;s:10:\"TANG, Doug\";i:8;s:15:\"TOWLE, Andrew C\";i:9;s:16:\"WALSH, Douglas S\";i:10;s:18:\"WILKERSON, Deborah\";i:11;s:11:\"ABUJA, Mary\";i:12;s:16:\"BAUER, Kristen M\";i:13;s:14:\"FAIX, Dennis J\";i:14;s:12:\"HAIT, Howard\";i:15;s:17:\"HENRICK, Jennifer\";i:16;s:15:\"JACOBS, Michael\";i:17;s:10:\"LISS, Alan\";i:18;s:14:\"LYNCH, Julia A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2013.04.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:2:\"28\";s:8:\"\u0000*\u0000spage\";s:4:\"2963\";s:8:\"\u0000*\u0000epage\";s:4:\"2971\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KUSCHNER\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Robert A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:16:\"RUSSELL, Kevin L\";i:1;s:6:\"QI LIU\";i:2;s:15:\"LYONS, Arthur G\";i:3;s:15:\"MALIK, Mohammad\";i:4;s:13:\"MOON, James E\";i:5;s:16:\"STUBBS, Jeremiah\";i:6;s:15:\"SUN, Wellington\";i:7;s:10:\"TANG, Doug\";i:8;s:15:\"TOWLE, Andrew C\";i:9;s:16:\"WALSH, Douglas S\";i:10;s:18:\"WILKERSON, Deborah\";i:11;s:11:\"ABUJA, Mary\";i:12;s:16:\"BAUER, Kristen M\";i:13;s:14:\"FAIX, Dennis J\";i:14;s:12:\"HAIT, Howard\";i:15;s:17:\"HENRICK, Jennifer\";i:16;s:15:\"JACOBS, Michael\";i:17;s:10:\"LISS, Alan\";i:18;s:14:\"LYNCH, Julia A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2013.04.035\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2013.04.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:2:\"28\";s:8:\"\u0000*\u0000spage\";s:4:\"2963\";s:8:\"\u0000*\u0000epage\";s:4:\"2971\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KUSCHNER\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Robert A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:16:\"RUSSELL, Kevin L\";i:1;s:6:\"QI LIU\";i:2;s:15:\"LYONS, Arthur G\";i:3;s:15:\"MALIK, Mohammad\";i:4;s:13:\"MOON, James E\";i:5;s:16:\"STUBBS, Jeremiah\";i:6;s:15:\"SUN, Wellington\";i:7;s:10:\"TANG, Doug\";i:8;s:15:\"TOWLE, Andrew C\";i:9;s:16:\"WALSH, Douglas S\";i:10;s:18:\"WILKERSON, Deborah\";i:11;s:11:\"ABUJA, Mary\";i:12;s:16:\"BAUER, Kristen M\";i:13;s:14:\"FAIX, Dennis J\";i:14;s:12:\"HAIT, Howard\";i:15;s:17:\"HENRICK, Jennifer\";i:16;s:15:\"JACOBS, Michael\";i:17;s:10:\"LISS, Alan\";i:18;s:14:\"LYNCH, Julia A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2013.04.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:2:\"28\";s:8:\"\u0000*\u0000spage\";s:4:\"2963\";s:8:\"\u0000*\u0000epage\";s:4:\"2971\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KUSCHNER\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Robert A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:16:\"RUSSELL, Kevin L\";i:1;s:6:\"QI LIU\";i:2;s:15:\"LYONS, Arthur G\";i:3;s:15:\"MALIK, Mohammad\";i:4;s:13:\"MOON, James E\";i:5;s:16:\"STUBBS, Jeremiah\";i:6;s:15:\"SUN, Wellington\";i:7;s:10:\"TANG, Doug\";i:8;s:15:\"TOWLE, Andrew C\";i:9;s:16:\"WALSH, Douglas S\";i:10;s:18:\"WILKERSON, Deborah\";i:11;s:11:\"ABUJA, Mary\";i:12;s:16:\"BAUER, Kristen M\";i:13;s:14:\"FAIX, Dennis J\";i:14;s:12:\"HAIT, Howard\";i:15;s:17:\"HENRICK, Jennifer\";i:16;s:15:\"JACOBS, Michael\";i:17;s:10:\"LISS, Alan\";i:18;s:14:\"LYNCH, Julia A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.vaccine.2013.04.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits\";s:9:\"\u0000*\u0000jtitle\";s:7:\"Vaccine\";s:9:\"\u0000*\u0000stitle\";s:7:\"Vaccine\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:2:\"28\";s:8:\"\u0000*\u0000spage\";s:4:\"2963\";s:8:\"\u0000*\u0000epage\";s:4:\"2971\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0264-410X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KUSCHNER\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Robert A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:16:\"RUSSELL, Kevin L\";i:1;s:6:\"QI LIU\";i:2;s:15:\"LYONS, Arthur G\";i:3;s:15:\"MALIK, Mohammad\";i:4;s:13:\"MOON, James E\";i:5;s:16:\"STUBBS, Jeremiah\";i:6;s:15:\"SUN, Wellington\";i:7;s:10:\"TANG, Doug\";i:8;s:15:\"TOWLE, Andrew C\";i:9;s:16:\"WALSH, Douglas S\";i:10;s:18:\"WILKERSON, Deborah\";i:11;s:11:\"ABUJA, Mary\";i:12;s:16:\"BAUER, Kristen M\";i:13;s:14:\"FAIX, Dennis J\";i:14;s:12:\"HAIT, Howard\";i:15;s:17:\"HENRICK, Jennifer\";i:16;s:15:\"JACOBS, Michael\";i:17;s:10:\"LISS, Alan\";i:18;s:14:\"LYNCH, Julia A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"VACCDE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
